Pentixapharm Holding AG · ISIN: DE000A40AEG0 · Directors Dealings
Insider Transaction Snapshot

Pentixapharm Holding AG

Directors Dealings: 4th October 2024
Reporting obligation triggered by: Eckert Wagniskapital und Frühphasenfinanzierung GmbH
Trading volume: 33.643.068,00 EUR
Type: not specified

The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 3rd October 2024. The order was executed at the trading place Frankfurter Wertpapierbörse. The aggregated volume was 33.643.068,00 EUR, based on an average price of 5,10 EUR. The nature of the Investment was not specified.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
This might be interesting for you as well
New DD.i/o
15 November 2023
Drägerwerk AG & Co. KGaA: A reportable insider transaction was published on 14th November 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 14th November 2023,

The Insider Transaction was made by Schrofner, Anton . The transaction toke place on 13th November 2023. . The aggregated volume was 30.480,00 EUR, based on an average price of 50,80 EUR. The nature of the Investment was not specified.

Drägerwerk AG & Co. KGaA
13 November 2023
Drägerwerk AG & Co. KGaA: A reportable insider transaction was published on 13th November 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 13th November 2023,

The Insider Transaction was made by Lescow, Gert-Hartwig . The transaction toke place on 10th November 2023. . The aggregated volume was 153.009,60 EUR, based on an average price of 50,80 EUR. The nature of the Investment was not specified.

Drägerwerk AG & Co. KGaA
09 November 2023
Drägerwerk AG & Co. KGaA: A reportable insider transaction was published on 9th November 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 9th November 2023,

The Insider Transaction was made by Dräger, Stefan . The transaction toke place on 7th November 2023. . The aggregated volume was 254.050,80 EUR, based on an average price of 50,80 EUR. The nature of the Investment was not specified.

Drägerwerk AG & Co. KGaA
11 November 2022
Drägerwerk AG & Co. KGaA: A reportable insider transaction was published on 11th November 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 11th November 2022,

The Insider Transaction was made by Lescow, Gert-Hartwig . The transaction toke place on 10th November 2022. . The aggregated volume was 333.864,75 EUR, based on an average price of 40,75 EUR. The nature of the Investment was not specified.

Drägerwerk AG & Co. KGaA
11 November 2022
Drägerwerk AG & Co. KGaA: A reportable insider transaction was published on 10th November 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 10th November 2022,

The Insider Transaction was made by Dräger, Stefan . The transaction toke place on 9th November 2022. . The aggregated volume was 305.625,00 EUR, based on an average price of 40,75 EUR. The nature of the Investment was not specified.

Drägerwerk AG & Co. KGaA
More Drägerwerk AG & Co. KGaA related information
Type Total Last Made by Go to
Equity Story 0 - - EQS
Corporate Research 0 - - Corporate Research
Short Seller (DE) 5 18th August 2015 JPMorgan Asset Management (UK) Ltd SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html